Medications

Inhaled amikacin reduces ventilatory-associated pneumonia

For critically ill patients undergoing mechanical ventilation for at least three days, a three-day course of inhaled amikacin reduces the subsequent burden of ventilatory-associated pneumonia, according to a study published ...

Medications

FDA approves Xacduro for difficult-to-treat bacterial pneumonia

The U.S. Food and Drug Administration has approved Xacduro (sulbactam for injection; durlobactam for injection) as a new treatment for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused ...

page 1 from 9